PURPOSE. Autosomal recessive retinitis pigmentosa (ARRP) is a genetically heterogeneous condition characterized by progressive loss of retinal photoreceptor cells. In order to gain new insights into the pathogenesis of ARRP, we evaluated the morphological, biochemical, and gene expression changes in eyes from a human donor with ARRP due to mutations in the ABCA4 gene.
T he term retinitis pigmentosa (RP) refers to a large number of syndromic and nonsyndromic heritable disorders characterized by progressive loss of vision due to degeneration of photoreceptor cells. The condition can be inherited in a dominant, recessive, X-linked, or oligogenic fashion.
1,2 Mutations in dozens of genes encoding proteins with highly diverse functions expressed in photoreceptor cells, retinal pigment epithelium (RPE), or choriocapillaris have been identified that are responsible for RP, with many more remaining to be discovered (reviewed in Ref. 1) .
One approach to developing an improved understanding of the pathogenesis of a rare disease is to examine biopsy or autopsy samples from the affected tissue. In the case of RP, several studies of human tissues have been performed and reveal the general characteristics of absent or severely reduced numbers of photoreceptor cells, pigment migration into the retina coincident with ''bone-spicule-like pigmentation'' and photoreceptor rosettes. [3] [4] [5] [6] In this study, eyes from a donor diagnosed with autosomal recessive RP (ARRP) were characterized histopathologically. We also examined the distribution of a number of histochemical markers of glial cells and other cell types and noted an increased degree of alkaline phosphatase activity in the degenerative retina that spatially colocalized with glial fibrillary acidic protein (GFAP). Sequencing of the ABCA4 gene identified both disease-causing alleles. Finally, expression microarray analysis of retinal tissue from the donor revealed the expected loss of differentiation markers of photoreceptor cells, as well as increased expression of glial markers and upregulation of a number of complement and inflammation genes. Transcripts encoded by genes expressed in inner retinal neurons were found to show continued expression. Preservation of some markers of inner retinal neurons suggests that second order neurons persist even in cases of advanced degeneration and may be able to be rescued.
METHODS Patient Description
The patient was first seen in our clinic at 35 years of age (in 1961). His visual acuity was counting fingers at less than two feet OU. The fundus examination revealed an area of grayish scarring, attenuation of the retinal vasculature, and significant intraretinal pigmentation in the posterior pole, while the peripheral retina and choroid appeared to be comparatively normal. The patient's family history was remarkable for one sister with RP ( Fig. 1) . The electroretinogram was nonrecordable under all stimulus conditions. The patient's visual acuity deteriorated to hand motions at 37 years of age and to light perception at 40 years. Bone spicule-like pigmentation, chorioretinal atrophy, and arteriolar narrowing were noted at that time ( Fig. 2A) . At 64 years of age, the patient had no light perception. Large clumps of pigment with RPE atrophy over the posterior 75% to 80% of the fundus were observed. The patient was followed periodically over the next decade and died at age 78.
Genetic Analysis
The Declaration of Helsinki was followed for all experiments with human samples. Genetic testing was performed to screen the entire coding sequence of the genes encoding rhodopsin (RHO) and rds (PRPH2), and the Arg677Stop mutation in RP1. For ABCA4, seven amplimers of coding sequence were screened for mutations by using automated bidirectional DNA sequencing. Screening of the proband was discontinued after two disease-causing alleles were detected. These variants were subsequently evaluated in two of the donor's unaffected siblings to determine whether the mutations were on the same or different alleles.
Eye Processing
At the request of his family, the patient's eyes were donated for research through the Iowa Lions Eye Bank (Iowa City, IA). The right eye was fixed by immersion in 4% formaldehyde solution in 10 mM phosphate-buffered saline. From the left eye, fragments of peripheral retina-RPE/choroid tissues were collected and flash frozen in liquid nitrogen within 7 hours of death. Due to scarring between the retina and choroid, these tissues were unable to be readily separated and were therefore collected and snap frozen together. A central-toperipheral wedge of the left eye was fixed for~2 hours and embedded in acrylamide solution for cryostat sectioning, as described previously. 7 A 6-mm dermal biopsy punch was used to collect four regions of the fixed right eye that included the macula centered on the fovea, an inferotemporal gliotic mass admixed with pigment, an inferonasal area of apparent complete atrophy (IN1), and a more peripheral inferonasal area with pigment that appeared intact (IN2). Locations of each of these samples are indicated in Figure 2B . Fixed tissues were infiltrated in sucrose solution prior to embedment in Optimal Cutting Temperature compound (Ted Pella, Redding, CA), as described previously. 8 Frozen sections were stained with hematoxylin-eosin stain or were used for histochemical analysis (described below). A control eye from a 63-year-old person with a similar postmortem preservation time was used for comparison to the RP eye.
Histological Methods
Immunohistochemical staining was performed using antibodies directed against rhodopsin (Santa Cruz Biotechnology, Santa Cruz, CA), glial fibrillar acidic protein (GFAP; Neomarkers), intercellular adhesion molecule-1 (ICAM-1; Developmental Studies Hybridoma Bank, Iowa City, IA), RPE65 (Chemicon, Temecula, CA), neurofilament heavy chain (Chemicon), and terminal complement complex (Dako). Endogenous phosphatase was detected using a nitroblue tetrazolium (NBT), 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) kit (Vector Laboratories). Labeling procedures were performed as described previously. 9, 10 Retinoid Analysis Paraformaldehyde-fixed human donor eyes were used for assessment of A2E levels. Disposable 6-mm trephines were used to collect peripheral punches of RPE-choroid from the left eye of the ARRP eye and from four additional, unaffected donors (ages 72, 76, 80, and 81). The region from the ARRP eye showed a complete loss of photoreceptor cells but had an intact RPE layer. Chloroform extracts of the eye punches were analyzed by normal phase on a silica column (Zorbax-Sil 5 lm, 250 mm · 4.6 mm; Agilent, Santa Clara, CA) in a high-performance liquid chromatograph (Agilent model 1100) equipped with a photodiode array detector (Agilent Technologies, Wilmington, DE). The method of extraction and analysis has been previously described. 11 
Microarray Analyses
A quadrant of the peripheral frozen retina-RPE-choroid complex from the left eye of this donor was used for microarray analysis. Briefly, RNA was isolated from the combined retina-RPE-choroid layers of the ARRP eye (RNeasy kit; Qiagen) and from regionally matched, pooled peripheral retina and RPE-choroid layers from an age-matched eye without retinal disease. The integrity of the isolated RNA was confirmed using a BioAnalyzer (Agilent). Reverse transcription, synthesis of complementary RNA, and hybridization to U133 plus 2.0 chips (Affymetrix, Santa Clara, CA) was performed as described in detail previously. 12, 13 Data were normalized using the robust microarray analysis algorithm. Only those probe sets that displayed expression values of at least 100 units in either the ARRP or the control eye were considered to be expressed and were evaluated further. Fold change ratios were determined between the ARRP eye and an unaffected control eye.
We also prospectively selected a limited number of cell typespecific genes to evaluate the status of different classes of cells in the degenerated retina. Transcripts of melanopsin, neurofilament heavy chain, and Thy1 were used to assess the integrity of ganglion cells, while transcripts of metabotropic glutamate receptor-6, calretinin, and parvalbumin were used for an assessment of bipolar and amacrine cells. Transcripts of GFAP and cellular retinaldehyde binding protein were used to evaluate astrocytes and Muller cells, while rhodopsin, ROM1, and red/green opsins were used for an assessment of photoreceptor cells. The integrity of the RPE was estimated by examining the transcripts of bestrophin-1 and RPE65, while the choriocapillaris was evaluated by quantifying transcripts of VEGFR2 and carbonic anhydrase IV.
RESULTS

Genetic Screening
Genetic screening of RHO, PRPH2, and the RP1 Arg677Stop variation did not detect any disease-causing mutations. In contrast, DNA sequencing of ABCA4 revealed two plausible disease-causing mutations: IVS14+1G > C (c.2160+1 G > C) and a novel mutation, Phe1440del1cT (c.4318del1cT), both in the heterozygous state.
Phase was established by sequencing two unaffected siblings for the two mutations identified in the proband. The proband's unaffected brother was found to carry only the Phe1440 del1cT mutation, whereas the proband's unaffected sister was found to harbor only the IVS14+1 variant, demonstrating that both mutations lie on different alleles (Fig. 1) .
Histological examination of eyes from this donor showed features consistent with other eyes with RP that have been described previously (e.g., loss of the outer nuclear layer and RPE migration into the neural retina) as summarized below. 
Hematoxylin-Eosin Stain
In each of the surveyed regions, photoreceptor cell loss appeared complete. The macular region showed complete loss of the outer nuclear layer, with some evidence of inner nuclear layer and ganglion cell layer preservation (Fig. 2C ). The RPE in the macula was discontinuous and in places showed migration into the outer aspect of the retina, with some cells forming a two-layered epithelium. The severely depigmented IN1 similarly showed loss of the outer nuclear layer with attenuation of the retina and choroid (Fig. 2D) . Remnants of pigmentation were detected in the choroid in scattered profiles. Bruch's membrane appeared to be intact in this region. The far peripheral IN2 punch showed a relatively normal RPE layer in which the RPE was continuous and showed normal polarity, although pigment density varied regionally, with RPE cells ranging from brown to black (Fig. 2E) . As in the other regions examined, however, a complete loss of outer nuclear layer and photoreceptor cells was observed. The inferotemporal region contained a large nevus with fibrovascular scar tissue between Bruch's membrane and the remnants of the neural retina. The RPE was observed in several island-like clumps at multiple layers through the scar and retina. Individual RPE cells were often hypertrophied and were present in three or more layers, in addition to accumulating around large vessels in the inner retina (Fig. 2I ). The choriocapillaris was atrophic in all regions examined except for the far peripheral inferonasal punch, in which localized islands of preserved choriocapillaris were present.
Autofluorescence
Areas of lipofuscin-laden RPE were observed in the inferonasal and inferotemporal punches. Autofluoresecent RPE cells were observed underlying retina completely devoid of photoreceptor cells (Figs. 3A and 3B). Hypofluorescent (deeply pigmented) and hyperfluorescent (normally pigmented) RPE cells were observed in this region, with a clear line of demarcation (Fig. 3 , arrows). Autofluorescence characteristics of Bruch's membrane appeared normal regardless of the level of RPE pigmentation.
Anti-Terminal Complement Complex C5b-9
Sections were labeled with an antibody directed against the C9 neoantigen that is exposed by complement activation. As described previously, [14] [15] [16] [17] C5b-9 labeling was observed in the macular region in Bruch's membrane and choriocapillary pillars and along the choriocapillaris (Fig. 3C ). In the RP eye, the degree of C5b-9 labeling observed was generally reduced compared with that of control eyes, suggesting a role for RPE in complement activation, although the site of complement deposition in these eyes (the choriocapillaris) was generally atrophied as well. In areas of intact choriocapillaris, labeling for C5b-9 was reduced compared to that in controls but was still detectable (Fig. 3A) . Figure 3 shows a field from the far peripheral inferonasal region in which RPE cells on the right half of the field are autofluorescent and overlying intact choriocapillaris, whereas the left half of the field shows hyperpigmented, nonautofluorescent RPE cells overlying an area of choriocapillaris dropout. Complement labeling in Bruch's membrane and the choriocapillaris was observed only Comparison of RPE lipofuscin (yellow-orange) and complement membrane attack complex (green) in the ARRP eye (A and B) and an age-matched control donor eye (C). Loss of RPE autofluorescence in dystrophic RPE (A and B) corresponds to loss of choroidal vasculature and decreased membrane attack complex labeling. Note the sharp demarcation between highly autofluorescent and hypofluorescent, deeply pigmented cells on either side of the arrow. Autofluorescent RPE cells were found to overlie an intact choriocapillaris, whereas nonautofluorescent RPE cells overlie an area of choriocapillaris dropout. Complement labeling in Bruch's membrane, and the choriocapillaris is observed only over the half of the field with intact capillaries and autofluorescent RPE. Merged images using FITC and tetramethyl rhodamine isothiocyanate filter sets are shown in A and C. (B) same field as A, exposed in brightfield. Bar = 50 lm.
over the half of the field with intact capillaries and autofluorescent RPE (Figs. 3A and 3C ).
Anti-GFAP
Labeling for GFAP in normal eyes was generally confined to the inner retina, along the nerve fiber layer and around large retinal vessels (Fig. 4A) . In each of the regions from the RP eye, however, GFAP labeling was more intense and more widely distributed through the retina. Although the greatest intensity of labeling remained in the innermost layers, labeling was also observed throughout the remaining thickness of the retina. This was least pronounced in the macular punch where the retina was thickest.
Alkaline Phosphatase Activity
In the right eye, alkaline phosphatase activity was not observed due to prolonged fixation. A more lightly fixed portion of the left eye was infiltrated in acrylamide and incubated with the alkaline phosphatase substrates NBT and BCIP. Whereas unaffected eyes showed reactivity of choroidal and retinal vasculature (Fig. 5A) , the RP eye exhibited more widespread labeling throughout the neural retina, over approximately the same area occupied by GFAP-reactive cells (Figs. 5B and 5C ). This pattern is similar to the migration columns described in animal models of retinal degeneration. 18 Vascular dropout was noted in both the retina and choroid. To verify that this activity was due to alkaline phosphatase, NBT and BCIP were also prepared in neutral (pH 7.5) and acidic (pH 3.5) buffers. No labeling was observed when these solutions were used (data not shown).
Peanut Agglutinin and Anti-Rhodopsin Antibody
In normal eyes, labeling of cone matrix sheaths and rod outer segments is readily detectable with peanut agglutinin (PNA) and anti-rhodopsin, respectively. In the RP eye, no evidence of immunoreactive cone or rod remnants was observed in any of the areas surveyed. In areas of retinal scarring, thin strands of PNA-binding material or cells were observed occasionally on the outer surface of the scar (data not shown).
A2E Fluorophores in ARRP
Quantification of different classes of lipofuscin fluorophores extracted from normal age-matched control eyes and the ARRP donor eye revealed that the total A2E level (defined as A2E plus iso-A2E) in the RPE underlying extremely degenerated retina of the ARRP eye was comparable to that in the normal RPE of the controls. Interestingly, whereas A2E showed similar overall levels, A2PE, a direct A2E precursor, was dramatically reduced in the ARRP eye. A2PE levels were 32% to 70% of control levels, with an average of 39.9%, reflecting significant loss of the photoreceptor cells as they are the primary source of bisretinoid formation.
Microarray Analyses
Combined neural retina and RPE/choroid layers were evaluated by microarray analysis for the ARRP donor and were compared with pooled retina/RPE/choroid layers from an unaffected donor. Due to the rarity of retinal tissue with ARRP, a rigorous statistical analysis of these data was not possible. However, Table 1 lists those genes with the largest difference in expression values, as determined by the fold change ratio (ARRP:control expression ratio). Several of these genes are represented by more than one probe set, and thus, the 100 probe sets with the most reduced expression in the RP eye correspond to 78 distinct genes. According to this analysis, the genes showing the greatest decrease in the RP eye were PDE6A, followed by CNGA1 and RHO. Notably, of the 78 genes with the most reduced expression, 28 genes are known to cause human retinal degeneration when mutated (see, e.g., RetNet; http://www.sph.uth.tmc.edu/retnet/).
Results of the reciprocal analysis of genes that are more abundantly expressed in the ARRP retina are given in Table 2 .
Genes showing increased expression in the RP eye included immunoglobulin superfamily genes (ICAM1, HLA-DPA1, HLA-DQB1, HLA-DOA, and ISLR) and a number of other proinflammatory genes, including complement pathway genes (CFB, C2, and complement gene homologs) and several cytokines and cytokine receptors (IL6, CXCL10, CXCL2) ( Table 2) .
We also examined a list of prospectively selected genes associated with different retinal cell types for expression changes in the ARRP eye (Table 3) . Consistent with our immunohistochemical findings, the expression of GFAP mRNA was increased as well. Interestingly, most of the assessed inner retinal neuron genes showed persistent expression, despite the structural alterations and plasticity observed in this eye. For example, genes encoding neurofilament heavy chain, Thy1, parvalbumin, and metabotropic glutamate receptor 6 showed continued expression despite severe retinal degeneration. As might be expected, genes expressed primarily by photoreceptor cells showed a profound decrease in expression.
DISCUSSION
The ABCA4 gene encodes a 2273-amino acid transmembrane protein of the photoreceptor outer segment disk, whose role is to couple the hydrolysis of ATP to the transport of a visual cycle intermediate, N-retinylidene-phosphatidylethanolamine, from the inner to the outer leaflet of the disk membrane. 19 Mutations in ABCA4 that reduce or abolish this flippase activity result in the formation of toxic bisretinoids that can either injure the photoreceptors directly or accumulate in the underlying RPE, causing dysfunction or loss of that tissue and secondary injury to the photoreceptors. The close physical relationship between the photoreceptors and the RPE and the fact that retinoids pass through both cell types during the course of the visual cycle explain in large measure the wide range of clinical findings that are observed in patients with ABCA4 dysfunction. The mildest disease-causing genotypes cause a disorder known as Stargardt disease; moderate genotypes cause selective injury to cone photoreceptors that are manifest clinically as cone or cone-rod dystrophy; and the most severe genotypes cause direct injury to both rod and cone photoreceptors, which appears clinically as ARRP [20] [21] [22] [23] (recently reviewed in Refs. 24 and 25) .
In this article, we report the first clinicopathologic study of the eyes of an individual affected with molecularly confirmed ABCA4-related ARRP. In most previous histopathological studies of retinitis pigmentosa, eye donors were believed to have an autosomal dominant form of the disease. [3] [4] [5] [6] [26] [27] [28] In this study, the donor's pedigree structure (Fig. 1) coupled with the finding that each of his two unaffected siblings shared one of his two disease-causing mutations in ABCA4 provide strong evidence for the diagnosis of ABCA4-associated ARRP in this patient. Specifically, the donor was found to carry two possible disease-causing ABCA4 variations: IVS14+1G > C, which he shared with his unaffected sister, and Phe1440del1cT, which he shared with his unaffected brother. Bioinformatic analysis suggests that the IVS14+1G > C mutation abolishes the donor splice site of intron 14. 29, 30 This mutation has been previously reported in Stargardt disease 31 but, to our knowledge, has not been observed in RP. The Phe1440del1cT frame shift mutation FIGURE 5 . Alkaline phosphatase activity in a control eye (A) and the ARRP eye (B and C). Normally alkaline phosphatase activity is restricted to retinal vessels (arrows) and choroidal endothelial cells. In the ARRP eye, elevated activity was observed throughout the inner retina (asterisks), presumably due to glial cell proliferation. Arrowheads indicate Bruch's membrane. GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer. Bar = 50 lm. One of the major motivations for studying human donor tissue from individuals affected with rare diseases is to gain sufficient insight into the pathogenesis of these diseases that more effective treatments can be developed. There are at least three treatment-related facts that this donor tissue allowed us to investigate: (1) the order in which the RPE and photoreceptors succumbed in the face of ABCA4 dysfunction; (2) the longevity of the inner retinal neurons following the loss of the photoreceptor cells; and (3) the list of human genes abundantly expressed in the outer retina, which could themselves be candidates for involvement in other forms of heritable photoreceptor disease.
The order in which the RPE and photoreceptors are lost in ABCA4-related retinal diseases is relevant to the design of both gene-and cell-based therapies for these conditions. If, for example, the RPE cells are always lost first and photoreceptor cells die only as a consequence of this RPE loss, then one might envision conferring some RPE resistance to bisretinoid accumulation using gene transfer of a modifying gene to these cells. Transfer of a normal ABCA4 gene to the RPE would not be expected to be helpful as this gene is not normally expressed in this cell type and would have no obvious physiologic role there. One could also consider replacing the injured RPE with stem cell-derived RPE cells, 33, 34 but that strategy alone might not be a permanent solution for a patient because the source of the toxic bisretinoids, the photoreceptors, would not be corrected with such a transplant. The situation is even more challenging if bisretinoid accumulation is directly toxic to the photoreceptor cells and if photoreceptors die in significant numbers before the loss of the RPE. In this case, treatments directed toward the RPE would only be helpful if coupled to a rescue or replacement of photoreceptor cells.
Our histological studies in this case revealed complete loss of the photoreceptors, which was consistent with the patient's clinical history of a complete inability to perceive light for decades. Our finding that some areas of the RPE were preserved beneath a completely atrophic outer nuclear layer supports the notion that photoreceptor loss precedes loss of the RPE in at least some cases of ABCA4-associated ARRP.
Immunohistochemical evaluation of the retina from this donor also revealed complete loss of photoreceptor-specific markers and an increase of GFAP immunoreactivity throughout the retina. Gliosis with increased expression of GFAP has been previously observed in association with RP. 35 We also observed upregulation of endogenous alkaline phosphatase activity. Alkaline phosphatase is a membrane protein that is a useful marker for vascular endothelial cells and is normally localized to viable retinal and choroidal vessels (Fig. 4A) . 36, 37 In our case, distribution of AP reactivity was observed throughout the retina, suggesting that AP upregulation may also be a marker of gliosis.
In addition to performing morphological studies, we also analyzed the retinoid levels in the donor tissue and compared them to those in unaffected control eyes. Quantification of A2E from the most intact region of the eye revealed that bisretinoids can persist for decades in eyes that are completely blind and have no morphological evidence of functional photoreceptor cells (Fig. 3) . In fact, the total A2E level in the ABCA4-associated RP eye was comparable to those in agematched controls with intact photoreceptor cells. However, A2PE, an immediate A2E precursor, was dramatically reduced in the RP eye compared to those in controls (39.9% of the average control value), consistent with the loss of the photoreceptor cells.
We also compared gene expression in the ABCA4-associated RP retina to that of an unaffected control. Given the advanced state of disease, differences in expression between the RP retina and the control retina are more reflective of differences in the viable cell populations of these specimens than they are of transcriptional differences within comparable cell types. Despite this limitation, several insights may be obtained from these data. First, many of the transcripts with decreased abundance in the RP retina correspond to genes that are known to cause inherited photoreceptor disease when they are mutated in humans. This is not terribly surprising because it has been known for decades that there is correspondence between genes with high photoreceptor expression and retinal disease. 38 Thus, the degree of decreased expression of a given gene in this RP eye is an indication that the gene is highly Table 1 lists genes recognized by the top 100 transcripts, showing decreased expression in the ARRP eye compared to an unaffected control eye. Note that several of the probe sets recognized genes that have not yet been annotated (probe set identifiers are appended in supplemental data, available at http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.12-9477/-/DCSupplemental). Genes known to be associated with human retinal disease (http://www.sph.uth.tmc.edu/retnet/) indicated by an asterisk. For cases in which multiple probe sets were present for a given gene, the average ratio is shown. expressed in the outer retina in a normal eye. In fact, there is a good correlation between these human microarray data and similar data obtained in mice deficient for Bbs4 (see supplemental tables in Ref. 12) , suggesting that cellular similarities exist in the late stages of RP regardless of species and specific genotype. The practical utility of this observation is that the list of genes with decreased mRNA abundance in the ABCA4-associated human RP retina and the Bbs4-associated murine RP retina includes RP-causing genes whose role in this disease have yet to be identified. This is of great interest because a large number of ARRP genes remain to be discovered, 1 and methods for evaluating such genes in moderate to large patient populations are rapidly improving.
Another group of genes with elevated expression levels in the RP retina encode proteins involved in immunological processes, such as ICAM1, MHC antigens, 39 and complement genes. With respect to complement genes, it is intriguing that upregulation of the complement system has been described in various animal models of retinal degeneration 40, 41 and, overall, supports a role for the immune system in either exacerbating damage or removing cellular debris from the injured retina. 42 These findings are also consistent with experiments that suggest a protective role for immune suppression in the degenerating retina. 43 Of greatest clinical relevance is our observation that sets of genes that are representative of multiple classes of inner retinal Table 2 lists genes recognized by the top 100 transcripts showing increased expression in the ARRP eye compared to an unaffected control eye. Several of the differentially expressed genes are involved in immune mediated processes. Several of the probe sets recognize genes that have not yet been annotated (probe set identifiers are appended in Supplemental Data available at http://www.iovs.org/lookup/suppl/doi:10.1167/iovs. 129477/-/DCSupplemental). For cases in which multiple probe sets were present for a given gene, the average ratio is shown. Table 3 lists relative expression of a small number of cell type-specific genes in the ARRP donor eye and a control eye. Preservation of several inner retina neuron specific transcripts is observed.
neurons were still expressed in the retina even after decades of no light perception (Table 3 ). The persistence of transcripts for bipolar, amacrine, and ganglion cells suggests that despite the extensive plasticity of the degenerating neural retina, 18, 44 there is persistence of some inner retinal neurons for many years after vision is lost. This preservation, at least at the molecular level, provides support for the possibility of successful intervention with stem cell-based photoreceptor replacement, 45 optogenetic sensitization of inner retinal neurons, 46 or prosthetic electrical stimulation of the inner retina, even very late in the clinical course of the disease.
